| Dr Christopher R Morse, MD | |
|
608 City Route 66, St. Robert, MO 65584 | |
| (573) 336-5100 | |
| (573) 336-3118 |
| Full Name | Dr Christopher R Morse |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 608 City Route 66, St. Robert, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811035728 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2000168907 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher R Morse, MD Po Box 2580, Springfield, MO 65801-2580 Ph: (417) 829-4620 | Dr Christopher R Morse, MD 608 City Route 66, St. Robert, MO 65584 Ph: (573) 336-5100 |
News Archive
"A longtime Miami-Dade healthcare operator and his son have been charged with bilking more than $2.8 million from Medicare in an undercover FBI case. The father has fled the country and the son is cooperating with authorities. Ernesto Angel Montaner and his son, Ernesto Montaner, are accused of operating a network of physical rehabilitation clinics in Miami-Dade that submitted millions of dollars in phony bills to the federal healthcare program for the elderly and disabled between 2003 and 2008" (Weaver, 4/24).
Young people who start smoking at an early age have a much higher risk of starting to use cannabis by the time they turn 17. Risk factors that increase the likelihood of starting to smoke include externalising problem behaviours such as impulsiveness. Smoking, in turn, is a significant risk factor for cannabis use. These results have been confirmed in a project researching smoking at an early age and externalising behaviour as predictors of drug use.
Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) announced it has completed its acquisition of Nycomed A/S for 9.6 billion Euro on a cash-free, debt-free basis and made Nycomed a wholly owned subsidiary of Takeda effective the same day. Dr. Frank Morich has been named CEO of Nycomed in addition to his current role as Executive Vice President (EVP), International Operations, Takeda Pharmaceuticals International, Inc., a wholly owned subsidiary of Takeda America Holdings, Inc.
Researchers have identified ketamine-induced brain-related changes that are responsible for maintaining the remission of behaviors related to depression in mice - findings that may help researchers develop interventions that promote lasting remission of depression in humans.
A new study looks at what problems affect people most after a stroke and it provides a broader picture than what some may usually expect to see.
› Verified 1 days ago
Dr. Debra A. Mccaul, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 608 City Route 66, St. Robert, MO 65584 Phone: 573-336-5100 Fax: 573-336-3118 | |
Dr. David M. Reid, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 608 City Route 66, St. Robert, MO 65584 Phone: 573-336-5100 Fax: 573-336-3118 | |
Jeffrey Semeyn, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 608 City Route 66, St. Robert, MO 65584 Phone: 573-336-5100 Fax: 573-336-3118 | |
Dr. Lara Salyer, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 608 City Route 66, St. Robert, MO 65584 Phone: 573-336-5100 Fax: 573-336-3118 |